Latest news - Novo Nordisk
2024年10月21日 · Latest news. 05 November 2024. Novo Nordisk's sales increased by 23% in Danish kroner and by 24% at constant exchange rates to DKK 204.7 billion in the first nine months of 2024. Read more. 01 November 2024. Novo Nordisk A/S: Semaglutide 2.4 mg demonstrates superior improvement in both liver fibrosis and MASH resolution in the …
Novo Nordisk Q3 2024 results
2024年11月6日 · Novo Nordisk on Wednesday reported a third-quarter beat on sales of its blockbuster weight-loss drug Wegovy and narrowed its 2024 full-year growth guidance. Company shares jumped early on...
Company announcements & press releases - Novo Nordisk
Novo Nordisk A/S: Semaglutide 2.4 mg demonstrates superior improvement in both liver fibrosis and MASH resolution in the ESSENCE trial. Novo Nordisk A/S: Oral semaglutide demonstrates a 14% reduction in risk of major adverse cardiovascular events in …
News Details - novonordisk.com
2024年10月21日 · Novo Nordisk A/S: Oral semaglutide demonstrates a 14% reduction in risk of major adverse cardiovascular events in adults with type 2 diabetes in the SOUL trial. Bagsværd, Denmark, 21 October 2024 — Novo Nordisk today announced the headline results from the SOUL cardiovascular outcomes trial.
Novo Nordisk Reports Headline Results From Part 1 Of ESSENCE …
2024年11月1日 · (RTTNews) - Novo Nordisk (NVO) announced the headline results from part 1 of the ongoing ESSENCE trial, a phase 3, 240-week, double-blinded trial in 1,200 adults with metabolic...
Novo Nordisk U.S. News & Media Hub | Novo Nordisk U.S.
Welcome to Novo Nordisk's U.S. news and media hub. Here you can access our news releases, social media accounts, media contacts, sign up for email alerts, and more.
Novo Nordisk to build $4.1 billion North Carolina facility to boost ...
2024年6月24日 · Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy,...
Novo Nordisk's Ozempic, Wegovy now available after shortages
2024年10月30日 · All doses of Novo Nordisk ’s highly popular weight loss injection Wegovy and diabetes drug Ozempic are now available in the U.S., according to an update on the U.S. Food and Drug...
Ozempic, Wegovy maker Novo Nordisk faces hearing over high …
2024年9月24日 · WASHINGTON — Sen. Bernie Sanders, I-Vt., on Tuesday extracted a meager commitment from Novo Nordisk CEO Lars Fruergaard Jørgensen to meet with pharmacy benefits managers to discuss lowering the...
Novo Nordisk unveils new US hub as R&D investments soar
2024年2月29日 · | Novo Nordisk executives unveiled the company's U.S. R&D hub on Wednesday, repurposing Dicerna's old headquarters as the new regional outpost.